Cargando…
Risk factors to identify patients who may not benefit from whole brain irradiation for brain metastases - a single institution analysis
BACKGROUND: Radiotherapy plays a major role in the management of brain metastases. This study aimed to identify the subset of patients with multiple brain metastases who may not benefit from whole brain irradiation (WBI) due to a short survival time regardless of treatment. METHODS: We analyzed a to...
Autores principales: | Buecker, Rebecca, Hong, Zhen-Yu, Liu, Xiao-Mei, Jaenke, Gert, Lu, Ping, Schaefer, Ulrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417259/ https://www.ncbi.nlm.nih.gov/pubmed/30866972 http://dx.doi.org/10.1186/s13014-019-1245-9 |
Ejemplares similares
-
The benefit of whole brain reirradiation in patients with multiple brain metastases
por: Ozgen, Zerrin, et al.
Publicado: (2013) -
PRO: Do We Still Need Whole-Brain Irradiation for Brain Metastases?
por: Popp, Ilinca, et al.
Publicado: (2023) -
Comparison of whole brain radiation therapy for synchronous brain metastases with irradiation protecting the hippocampus versus whole brain radiotherapy for sequential brain metastases to boost irradiation in the treatment of brain metastases from SCLC: study protocol for a randomized controlled trial
por: Zhang, Xiaofang, et al.
Publicado: (2022) -
Single institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases
por: Jiang, Cecilia, et al.
Publicado: (2021) -
Rationale for the Use of Upfront Whole Brain Irradiation in Patients with Brain Metastases from Breast Cancer
por: Tallet, Agnes V., et al.
Publicado: (2014)